Following a huge outcry from drugmakers, insurance companies, and patient advocates, the Obama administration said Monday it had abandoned proposed changes to the Medicare Part D drug benefit.
written on 11.03.2014
Pharma wins battle against proposed Medicare reimbursement changes
